- Home
- BTMD vs STIM Comparison
BTMD vs STIM Comparison
Compare BTMD & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTMD
- STIM
- Stock Information
- Founded
- BTMD 2012
- STIM 2003
- Country
- BTMD United States
- STIM United States
- Employees
- BTMD N/A
- STIM N/A
- Industry
- BTMD Medicinal Chemicals and Botanical Products
- STIM Medical/Dental Instruments
- Sector
- BTMD Health Care
- STIM Health Care
- Exchange
- BTMD Nasdaq
- STIM Nasdaq
- Market Cap
- BTMD 177.7M
- STIM 192.0M
- IPO Year
- BTMD N/A
- STIM 2018
- Fundamental
- Price
- BTMD $4.49
- STIM $4.13
- Analyst Decision
- BTMD Strong Buy
- STIM Buy
- Analyst Count
- BTMD 3
- STIM 4
- Target Price
- BTMD $10.00
- STIM $4.67
- AVG Volume (30 Days)
- BTMD 165.8K
- STIM 2.1M
- Earning Date
- BTMD 03-11-2025
- STIM 03-04-2025
- Dividend Yield
- BTMD N/A
- STIM N/A
- EPS Growth
- BTMD N/A
- STIM N/A
- EPS
- BTMD 0.21
- STIM N/A
- Revenue
- BTMD $193,060,000.00
- STIM $72,711,000.00
- Revenue This Year
- BTMD $9.22
- STIM $3.23
- Revenue Next Year
- BTMD $14.46
- STIM $29.55
- P/E Ratio
- BTMD $21.35
- STIM N/A
- Revenue Growth
- BTMD 4.84
- STIM 5.03
- 52 Week Low
- BTMD $4.45
- STIM $0.52
- 52 Week High
- BTMD $8.44
- STIM $5.07
- Technical
- Relative Strength Index (RSI)
- BTMD 35.80
- STIM 59.06
- Support Level
- BTMD $4.49
- STIM $2.80
- Resistance Level
- BTMD $5.00
- STIM $5.03
- Average True Range (ATR)
- BTMD 0.29
- STIM 0.49
- MACD
- BTMD 0.00
- STIM 0.04
- Stochastic Oscillator
- BTMD 4.35
- STIM 59.64
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.